From Physical Amplification to Biological Effect: The Evolving Landscape of Nucleic Acid Nanomedicines in Radio-Immunotherapy
iMed · 2026
DOI: 10.70322/imed.2026.10007 ↗Kurz gefasst
Fachartikel in der Zeitschrift iMed, 2026. Verfasst von Long Chuxuan und 5 weiteren Autor:innen. Die Arbeit nennt 153 Literaturangaben.
Abstract (Originalsprache)
Radiotherapy (RT) remains a mainstay of cancer treatment, but its efficacy is limited by radioresistance and immunosuppression. Nucleic acid therapeutics, including siRNA, microRNA modulators, antisense oligonucleotides, aptamers, CpG oligodeoxynucleotides, and CRISPR systems, can remodel tumor responses at multiple levels. Nanotechnology enables their precise delivery, protection, and spatiotemporal activation. This review synthesizes recent advances in nucleic acid-enabled radiosensitization across four dimensions: (1) precise delivery via passive/active targeting and radiation-triggered release; (2) target selection from dominant-node inhibition to coordinated network regulation; (3) immune remodeling from checkpoint blockade to active immune instruction; and (4) multimodal integration where RT serves as a biological switch. We formally define programmable radio-nanomedicine as the co-design of nucleic acid cargo, carrier logic, activation trigger, and radiation schedule so that irradiation acts as a context-defining event. Translational barriers and a framework for next-generation design are discussed.
Zitieren
APA
Chuxuan, L., Yi, Z., Namei, J., Xiumei, M., Chunlin, S., & Yuexia, X. (2026). From Physical Amplification to Biological Effect: The Evolving Landscape of Nucleic Acid Nanomedicines in Radio-Immunotherapy. iMed. https://doi.org/10.70322/imed.2026.10007
Vancouver
Chuxuan L, Yi Z, Namei J, Xiumei M, Chunlin S, Yuexia X. From Physical Amplification to Biological Effect: The Evolving Landscape of Nucleic Acid Nanomedicines in Radio-Immunotherapy. iMed. 2026. doi:10.70322/imed.2026.10007
BibTeX
@article{Chuxuan2026,
author = {Chuxuan, Long and Yi, Zhu and Namei, Ji and Xiumei, Ma and Chunlin, Shao and Yuexia, Xie},
title = {From Physical Amplification to Biological Effect: The Evolving Landscape of Nucleic Acid Nanomedicines in Radio-Immunotherapy},
journal = {iMed},
year = {2026},
doi = {10.70322/imed.2026.10007}
}
EUVIMED